de Haan A, van der Gun I, Hepkema B G, de Boer W J, van der Bij W, de Leij L F, Prop J
Department of Cardiopulmonary Surgery, University Hospital Groningen, The Netherlands.
Transplantation. 2000 Apr 15;69(7):1434-9. doi: 10.1097/00007890-200004150-00038.
Decreased in vitro T cell alloreactivity, demonstrated by decreased frequencies of peripheral blood donor-specific T cell precursors, may reflect a tolerant state after transplantation and lower the risk for development of chronic graft dysfunction. It is unknown whether a decrease in donor-specific T cell frequencies also occurs after clinical lung transplantation and if such a decrease lowers the risk for bronchiolitis obliterans syndrome (BOS), a hallmark of chronic graft dysfunction. Therefore, we compared changes in posttransplant donor-specific cytotoxic T lymphocyte (CTLp) and helper T lymphocyte precursor (HTLp) frequencies in lung allograft recipients with good graft function and in recipients with BOS.
Donor and third party specific CTLp and HTLp frequencies were determined by limiting dilution assay in pre- and posttransplant (1 year) peripheral blood samples of lung allograft recipients with good graft function (n = 13) and BOS (n = 10).
In recipients with good graft function, mean donor-specific CTLp frequencies decreased after transplantation (183 vs. 16 precursors before and after transplantation, respectively). Additionally, HTLp frequencies decreased but this was not specific for donor alloantigens because third party-specific HTLp frequencies decreased also. Surprisingly, recipients with BOS also showed a decrease in mean donor-specific CTLp frequencies after transplantation (332 vs. 49 precursors before and after transplantation, respectively). Again, HTLp frequencies decreased nonspecifically.
We conclude that donor-specific CTLp frequencies decrease after lung transplantation, but that this does not result in transplantation tolerance protecting the lung against the development of chronic graft dysfunction.
外周血供体特异性T细胞前体频率降低所表明的体外T细胞同种异体反应性降低,可能反映移植后的耐受状态,并降低慢性移植物功能障碍发生的风险。临床肺移植后供体特异性T细胞频率是否也会降低,以及这种降低是否会降低闭塞性细支气管炎综合征(BOS)(慢性移植物功能障碍的一个标志)的发生风险尚不清楚。因此,我们比较了移植肺功能良好的受者和患有BOS的受者移植后供体特异性细胞毒性T淋巴细胞(CTLp)和辅助性T淋巴细胞前体(HTLp)频率的变化。
通过有限稀释法测定移植肺功能良好的受者(n = 13)和患有BOS的受者(n = 10)移植前和移植后(1年)外周血样本中供体和第三方特异性CTLp和HTLp频率。
在移植肺功能良好的受者中,移植后平均供体特异性CTLp频率降低(移植前后分别为183和16个前体)。此外,HTLp频率降低,但这并非供体同种异体抗原所特有,因为第三方特异性HTLp频率也降低了。令人惊讶的是,患有BOS的受者移植后平均供体特异性CTLp频率也降低(移植前后分别为332和49个前体)。同样,HTLp频率非特异性降低。
我们得出结论,肺移植后供体特异性CTLp频率降低,但这并不会导致移植耐受以保护肺免受慢性移植物功能障碍的发展。